James N. Woody - 15 Dec 2023 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ATNF
Reported as of: 15 Dec 2023
Net transaction value: +$4,700
SEC form: 4
Accepted by SEC: 18 Dec 2023, 16:15:16 UTC
Prior SEC filing: 08 Sep 2023
Source filing: View source filing
Reporting owner signature: /s/ James N. Woody

Key filing fact

James N. Woody filed Form 4 for 180 Life Sciences Corp. (ATNF) on 18 Dec 2023.

Key facts

This page summarizes James N. Woody's Form 4 filing for 180 Life Sciences Corp. (ATNF).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Dec 2023, 16:15.

Change

Previous filing in this sequence was filed on 08 Sep 2023.
Current net transaction value: +$4,700.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATNF transaction

Common Stock

Purchase

Transaction value: $4,700
Shares: +25,000
Change %: +60%
Price: $0.1880
Shares after: 66,888
Date: 15 Dec 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Effective on December 15, 2023, Dr. James N. Woody, the Chief Executive Officer of the Issuer, purchased 25,000 shares of common stock of the Issuer from Prof. Sir Marc Feldmann, the Co-Executive Chairman of the Issuer, in a private transaction, for $4,720 or $0.188 per share, the closing sales price of the Issuer's common stock on such effective date.